Tuoxin Pharmaceutical Group (301089.SZ)'s application for issuing shares to specific targets has passed the Shenzhen Stock Exchange's review.

Tuoxin Pharmaceutical Group (301089.SZ) announced that on November 1, 2026, the company received the "Notification Letter from the Review Center Regarding Tuoxin Pharmaceutical Group Co., Ltd.'s Application to Issue Shares to Specific Targets" issued by the Shenzhen Stock Exchange. The Shenzhen Stock Exchange's issuance and listing review body reviewed the company's application documents for issuing shares to specific targets and concluded that the company meets the issuance conditions, listing conditions, and information disclosure requirements. Subsequently, the Shenzhen Stock Exchange will, in accordance with regulations, submit the matter to the China Securities Regulatory Commission to carry out the relevant registration procedures.